| Type of | January | February | March | April | May | June | Total ($M) | ||
| financing | |||||||||
| Public offerings | 542.2 | 486.8 | 922.3 | 574.3 | 267.8 | 317.4 | 3,110.68 |
| Private biotechs | 476.3 | 306.3 | 380.8 | 377.1 | 511.6 | 398.1 | 2,450.18 |
| Public/other | 386.5 | 532.5 | 1,214.1 | 1,945.1 | 424.6 | 228.6 | 4,731.36 |
| Total ($M) | 1,405.0 | 1,325.6 | 2,517.2 | 2,896.4 | 1,203.9 | 944.1 | 10,292.22 |
| Notes: |
| Public offerings = Initial, follow-on. |
| Private biotechs = Financings of private firms. |
| Public/other = Other financings of public companies, including loans, bridge financings, exercises of warrants, debt offerings, rights offerings, standard private placements, PIPE financings and institutional offerings of registered stock. |